Section Arrow
ILMN.NASDAQ
- Illumina
Quotes are at least 15-min delayed:2025/11/08 10:28 EST
Regular Hours
Last
 121.9
+0.79 (+0.65%)
Day High 
122.08 
Prev. Close
121.11 
1-M High
126 
Volume 
1.13M 
Bid
121.65
Ask
122.24
Day Low
119.36 
Open
120.21 
1-M Low
88 
Market Cap 
18.51B 
Currency USD 
P/E 26.7 
%Yield -- 
10-SMA 109.62 
20-SMA 102.81 
50-SMA 100.06 
52-W High 153.06 
52-W Low 68.7 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
4.46/4.98
Enterprise Value
20.55B
Balance Sheet
Book Value Per Share
15.58
Cash Flow
Cash Flow Yield
0.06
Income Statement
Total Revenue
4.37B
Operating Revenue Per Share
29.20
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SHCSotera Health Company15.68-0.33-2.06%77.15PE
NEOGNeogen Corp6.4+0.42+7.02%879PE
OPKOPKO Health1.34-0.04-2.90%-- 
DHRDanaher Corp209.94-0.73-0.35%43.47PE
EXASExact Sciences Corp66.18-1.04-1.55%-- 
Quotes are at least 15-min delayed:2025/11/08 10:28 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.